CFC2
MCID: CRD163
MIFTS: 26

Cardiofaciocutaneous Syndrome 2 (CFC2)

Categories: Cardiovascular diseases, Fetal diseases, Genetic diseases, Neuronal diseases, Rare diseases, Skin diseases

Aliases & Classifications for Cardiofaciocutaneous Syndrome 2

MalaCards integrated aliases for Cardiofaciocutaneous Syndrome 2:

Name: Cardiofaciocutaneous Syndrome 2 57 74 29 6 72
Cfc2 57 74
Cardiofaciocutaneous Syndrome, Type 2 40

Characteristics:

HPO:

32
cardiofaciocutaneous syndrome 2:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

UMLS 72 C3809005

Summaries for Cardiofaciocutaneous Syndrome 2

UniProtKB/Swiss-Prot : 74 Cardiofaciocutaneous syndrome 2: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1.

MalaCards based summary : Cardiofaciocutaneous Syndrome 2, is also known as cfc2. An important gene associated with Cardiofaciocutaneous Syndrome 2 is KRAS (KRAS Proto-Oncogene, GTPase). Affiliated tissues include heart, skin and liver, and related phenotypes are low-set ears and high palate

OMIM : 57 Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects, and mental retardation (summary by Niihori et al., 2006). In a phenotypic comparison of BRAF (164757)-positive and KRAS-positive individuals with CFC, Niihori et al. (2006) observed that patients with KRAS mutations did not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma, that were present in patients with BRAF mutation. (615278)

Related Diseases for Cardiofaciocutaneous Syndrome 2

Symptoms & Phenotypes for Cardiofaciocutaneous Syndrome 2

Human phenotypes related to Cardiofaciocutaneous Syndrome 2:

32 (show all 15)
# Description HPO Frequency HPO Source Accession
1 low-set ears 32 HP:0000369
2 high palate 32 HP:0000218
3 ptosis 32 HP:0000508
4 coarse facial features 32 HP:0000280
5 global developmental delay 32 HP:0001263
6 anteverted nares 32 HP:0000463
7 myopia 32 HP:0000545
8 mitral valve prolapse 32 HP:0001634
9 broad forehead 32 HP:0000337
10 fine hair 32 HP:0002213
11 curly hair 32 HP:0002212
12 sparse hair 32 HP:0008070
13 peripheral axonal neuropathy 32 HP:0003477
14 posteriorly rotated ears 32 HP:0000358
15 absent eyebrow 32 HP:0002223

Clinical features from OMIM:

615278

Drugs & Therapeutics for Cardiofaciocutaneous Syndrome 2

Search Clinical Trials , NIH Clinical Center for Cardiofaciocutaneous Syndrome 2

Genetic Tests for Cardiofaciocutaneous Syndrome 2

Genetic tests related to Cardiofaciocutaneous Syndrome 2:

# Genetic test Affiliating Genes
1 Cardiofaciocutaneous Syndrome 2 29 KRAS

Anatomical Context for Cardiofaciocutaneous Syndrome 2

MalaCards organs/tissues related to Cardiofaciocutaneous Syndrome 2:

41
Heart, Skin, Liver, Bone, Bone Marrow

Publications for Cardiofaciocutaneous Syndrome 2

Articles related to Cardiofaciocutaneous Syndrome 2:

(show all 14)
# Title Authors PMID Year
1
Two novel germline KRAS mutations: expanding the molecular and clinical phenotype. 8 71
21797849 2012
2
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. 8 71
16474404 2006
3
Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes. 71
23059812 2013
4
The diagnosis of Costello syndrome: nomenclature in Ras/MAPK pathway disorders. 71
18386799 2008
5
Peripheral neuropathy in cardiofaciocutaneous syndrome. 8
17437909 2007
6
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. 71
17056636 2007
7
Cardiofaciocutaneous Syndrome 71
20301365 2007
8
Germline KRAS mutations cause Noonan syndrome. 71
16474405 2006
9
Cardiofaciocutaneous syndrome (CFC) with congenital peripheral neuropathy and nonorganic malnutrition: an autopsy study. 8
16007634 2005
10
Cardio-facio-cutaneous (CFC) syndrome--a distinct entity? Report of three patients demonstrating the diagnostic difficulties in delineation of CFC syndrome. 8
9272711 1997
11
Adsorption of cadmium and lead ions by phosphoric acid-modified biochar generated from chicken feather: Selective adsorption and influence of dissolved organic matter. 38
31408776 2019
12
Improvement of the bioluminescence reporter system for real-time monitoring of circadian rhythms in the cyanobacterium Synechocystis sp. strain PCC 6803. 38
15824452 2005
13
Chick CFC controls Lefty1 expression in the embryonic midline and nodal expression in the lateral plate. 38
11397007 2001
14
The proliferative status of haematopoietic progenitor cells in the developing murine liver and adult bone marrow. 38
9877299 1998

Variations for Cardiofaciocutaneous Syndrome 2

ClinVar genetic disease variations for Cardiofaciocutaneous Syndrome 2:

6
# Gene Variation Type Significance SNP ID GRCh37 Pos GRCh38 Pos
1 KRAS NM_004985.5(KRAS): c.15A> T (p.Lys5Asn) single nucleotide variant Pathogenic rs104894361 12:25398304-25398304 12:25245370-25245370
2 KRAS NM_004985.5(KRAS): c.468C> G (p.Phe156Leu) single nucleotide variant Pathogenic rs104894362 12:25362828-25362828 12:25209894-25209894
3 KRAS NM_004985.5(KRAS): c.211T> C (p.Tyr71His) single nucleotide variant Pathogenic rs387907205 12:25380247-25380247 12:25227313-25227313
4 KRAS NM_004985.5(KRAS): c.65A> G (p.Gln22Arg) single nucleotide variant Pathogenic rs727503110 12:25398254-25398254 12:25245320-25245320
5 KRAS NM_004985.5(KRAS): c.458A> T (p.Asp153Val) single nucleotide variant Pathogenic rs104894360 12:25362838-25362838 12:25209904-25209904
6 KRAS NM_004985.5(KRAS): c.178G> C (p.Gly60Arg) single nucleotide variant Pathogenic rs104894359 12:25380280-25380280 12:25227346-25227346
7 KRAS NM_004985.5(KRAS): c.439A> G (p.Lys147Glu) single nucleotide variant Pathogenic/Likely pathogenic rs387907206 12:25378559-25378559 12:25225625-25225625
8 KRAS NM_004985.5(KRAS): c.101C> G (p.Pro34Arg) single nucleotide variant Pathogenic/Likely pathogenic rs104894366 12:25398218-25398218 12:25245284-25245284
9 KRAS NM_004985.5(KRAS): c.112-5C> T single nucleotide variant Uncertain significance 12:25380351-25380351 12:25227417-25227417

UniProtKB/Swiss-Prot genetic disease variations for Cardiofaciocutaneous Syndrome 2:

74
# Symbol AA change Variation ID SNP ID
1 KRAS p.Pro34Arg VAR_026110 rs104894366
2 KRAS p.Gly60Arg VAR_026112 rs104894359
3 KRAS p.Gln22Glu VAR_064850
4 KRAS p.Tyr71His VAR_069784 rs387907205
5 KRAS p.Lys147Glu VAR_069785 rs387907206

Expression for Cardiofaciocutaneous Syndrome 2

Search GEO for disease gene expression data for Cardiofaciocutaneous Syndrome 2.

Pathways for Cardiofaciocutaneous Syndrome 2

GO Terms for Cardiofaciocutaneous Syndrome 2

Sources for Cardiofaciocutaneous Syndrome 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....